Treatment of spinal anaesthesia-induced hypotension with cafedrine/theodrenaline versus ephedrine during caesarean section: Results from HYPOTENS, a national, multicentre, prospective, noninterventional study

Eur J Anaesthesiol. 2021 Oct 1;38(10):1067-1076. doi: 10.1097/EJA.0000000000001474.

Abstract

Background: In Germany, hypotension induced by spinal anaesthesia is commonly treated with a combination of cafedrine hydrochloride (C, 200 mg) and theodrenaline hydrochloride (T, 10 mg) in 2 ml. We compared the effectiveness of C/T with ephedrine.

Objectives: The primary objectives were to assess the speed of onset and the ability to restore blood pressure without an increase in heart rate. Secondary objectives were to evaluate maternal/foetal outcomes and the number of required additional boluses or other additional measures.

Design: HYPOTENS was a national, multicentre, prospective, open-label, two-armed, noninterventional study comparing C/T with ephedrine in two prospectively defined cohorts. This study relates to the cohort of patients receiving spinal anaesthesia for caesarean section.

Setting: German hospitals using either C/T or ephedrine in their routine clinical practice.

Patients: Women aged at least 18 years receiving spinal anaesthesia for caesarean section.

Interventions: Bolus administration of C/T or ephedrine at the discretion of the attending anaesthesiologist.

Main outcome measures: Endpoints within 15 min after initial administration of C/T or ephedrine were area under the curve between the observed SBP and the minimum target SBP; and incidence of newly occurring heart rate of at least 100 beats min-1.

Results: Although effective blood pressure stabilisation was achieved with both treatments, this effect was faster and more pronounced with C/T (P < 0.0001). The incidence of tachycardia and changes in heart rate were higher with ephedrine (P < 0.01). Fewer additional boluses (P < 0.01) were required with C/T. Although favourable neonatal outcomes were reported in both groups, base deficit and lactate values were greater with ephedrine (P < 0.01). Physician satisfaction was higher with C/T.

Conclusions: After C/T, tachycardia was not a problem, providing an advantage over ephedrine. Fewer additional boluses were required with C/T, suggesting greater effectiveness. An increased base deficit with ephedrine suggests reduced oxygen supply or increased demands in foetal circulation.

Trials registration: Clinicaltrials.gov: NCT02893241, German Clinical Trials Register: DRKS00010740.

Publication types

  • Multicenter Study

MeSH terms

  • Adolescent
  • Adult
  • Anesthesia, Obstetrical* / adverse effects
  • Anesthesia, Spinal* / adverse effects
  • Cesarean Section
  • Ephedrine
  • Female
  • Humans
  • Hypotension* / chemically induced
  • Hypotension* / diagnosis
  • Hypotension* / drug therapy
  • Hypotension, Controlled*
  • Infant, Newborn
  • Norepinephrine / analogs & derivatives
  • Phenylpropanolamine / analogs & derivatives
  • Pregnancy
  • Prospective Studies
  • Theophylline / analogs & derivatives
  • Vasoconstrictor Agents / adverse effects

Substances

  • Vasoconstrictor Agents
  • cafedrine
  • Phenylpropanolamine
  • Theophylline
  • Ephedrine
  • theodrenaline
  • Norepinephrine

Associated data

  • ClinicalTrials.gov/NCT02893241
  • DRKS/DRKS00010740